PubMed HealthSearch

PubMed · 1576443

Hematological testing.

Abstract

Hematological testing is a routine aspect of health care. It is invaluable for determining the physiological status of a patient, screening for indicators of systemic disease, determining a differential diagnosis, monitoring the effectiveness of therapeutic drugs, and justifying the management plans of both ocular and systemic conditions. Since doctors of optometry continue to provide a greater spectrum of medical care to patients, it is imperative that appropriate use be made of this important clinical adjunct to the practice of primary care. This paper reviews the use of hematological testing within optometry by discussing the various elements of the complete blood count and by describing selected diseases of the eye and visual system that are associated with hematological disorders.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Dayhaw-Barker. 1992. Hematological testing.. https://pubmed.ncbi.nlm.nih.gov/1576443/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[The therapy of the heparin-induced thrombosis-thrombocytopenia syndrome with immunoglobulins].

A 51-year-old obese woman who had just undergone a second osteotomy for arthrosis of the hip joint was given unfractionated heparin, 7,500 IU subcutaneously three times daily, as thrombosis prophylaxis. Signs of fulminant pulmonary embolism occurred on the 16th postoperative day with a platelet count of 33,000/microliters. Suspected heparin-induced thrombocytopenia and thrombosis (HITT) was confirmed by platelet tests. When heparin had been discontinued immunoglobulin G was administered, seven times 5 g intravenously, in view of the immunological genesis of HITT. In addition thrombolysis treatment with streptokinase combined with phenprocoumon was undertaken, until satisfactory anticoagulation was achieved after 4 days. Platelet count rose to 136,000/microliters within 20 hours of the first immunoglobulin dose. Complete clinical normality was restored, scintigraphy showed no perfusion deficit in the lungs.

Blood Cell Count